Evidence map›Paper›PMID 41814229›Full record

ArticleBMC medical imaging2026

Predicting recurrent chest pain in patients with myocardial bridging using explainable machine learning: a multicenter study integrating CT-derived functional and inflammatory imaging biomarkers.

Jingquan Hu, Kuigang He, Jing Luo, Rui Xia, Yufeng Zhang, Xiaolong Ma, Zhihong Shao, Xiaolong Gao

Abstract readMulticenter Study
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingquan Hu *Department of Radiology, Luodian Hospital, Shanghai University School of Medicine, Luodian Hospital of Baoshan District, Shanghai, China.
Kuigang He *Department of Radiology, Luodian Hospital, Shanghai University School of Medicine, Luodian Hospital of Baoshan District, Shanghai, China.
Jing Luo *Department of Radiology, Luodian Hospital, Shanghai University School of Medicine, Luodian Hospital of Baoshan District, Shanghai, China.
Rui XiaDepartment of Radiology, Luodian Hospital, Shanghai University School of Medicine, Luodian Hospital of Baoshan District, Shanghai, China.
Yufeng ZhangDepartment of Radiology, Luodian Hospital, Shanghai University School of Medicine, Luodian Hospital of Baoshan District, Shanghai, China.
Xiaolong MaDepartment of Radiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China. tilt22@sina.com.cn.
Zhihong ShaoDepartment of Radiology, Shibei Hospital of Jing'an District, Shanghai, China. 13621724030@163.com.
Xiaolong GaoDepartment of Radiology, Luodian Hospital, Shanghai University School of Medicine, Luodian Hospital of Baoshan District, Shanghai, China. gao_xiaolong@tongji.edu.cn.ORCID 0000-0002-6203-2951

Funding

2024 Medical and Health Research Fund of the Baoshan District Science and Technology Committee 2024-E-47
6 · The paper itself

Abstract

backgroundMyocardial bridging (MB) is a common congenital coronary anomaly that is increasingly recognized as a potential cause of myocardial ischemia and recurrent chest pain, even in the absence of obstructive coronary artery disease. However, reliable noninvasive risk stratification for recurrent chest pain in patients with MB remains challenging. Advanced coronary computed tomography angiography (CCTA)–derived biomarkers, including CT-based fractional flow reserve (CT-FFR) and the pericoronary fat attenuation index (FAI), may capture complementary functional and inflammatory mechanisms underlying MB-related symptoms, but their combined prognostic value has not been fully clarified.

methodsPatients diagnosed with myocardial bridging on CCTA were consecutively enrolled. Clinical characteristics and CCTA-derived anatomical, functional, and inflammatory parameters were systematically collected. Recurrent chest pain during follow-up was defined based on standardized clinical criteria. After feature selection using Cox proportional hazards regression, a random survival forest (RSF) model was constructed to predict recurrent chest pain. Model performance was evaluated using concordance indices and time-dependent receiver operating characteristic analyses. Model interpretability was assessed using Shapley additive explanations (SHAP).

resultsA total of 174 patients with MB were included and 54 patients (31.03%) experienced recurrent chest pain during follow-up. Multivariable analysis identified advanced age, female sex, diastolic luminal stenosis of the bridged segment, systolic compression index, CT-FFR ≤ 0.80, elevated FAI and increased pericoronary adipose tissue (PCAT) volume as independent predictors of recurrent chest pain. SHAP-based interpretability analysis demonstrated that the predictive model achieved good discrimination, with area under the receiver operating characteristic curve (AUC) values of 0.895 (95% CI, 0.854–0.926) in the training cohort, 0.837 (95% CI, 0.781–0.889) in the validating cohort, and 0.804 (95% CI, 0.718–0.872) in the independent testing cohort.

conclusionsAn explainable machine learning model integrating CT-derived functional and inflammatory imaging biomarkers supports individualized prediction of recurrent chest pain in patients with myocardial bridging. This approach may improve noninvasive risk stratification and support personalized clinical decision-making.

Indexed as

Chest PainComputed Tomography AngiographyMachine LearningMyocardial BridgingBiomarkersCoronary AngiographyFemaleFractional Flow Reserve, MyocardialHumansMaleMiddle AgedPrognosisRecurrenceRisk AssessmentROC CurveBiomarkersCT-FFRFAIMachine learningMyocardial bridgingRecurrent chest pain

Identifiers

PMID41814229
PMCPMC13088861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.